Table 1 The 21 patients in Fig. 3 and the time interval for monitoring M-protein during chemotherapy.
Patient number | Sex | Age (years) | Newly diagnosed at the first monitoring | Interval between the monitoring point and the previous one (days) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | ||||
1 | F | 66 | Yes | 0 | 37 | 33 | 35 | 29 | 34 | 30 |
The 8th to 9th monitoring | 45 | 29 | ||||||||
2 | F | 50 | No | 0 | 44 | 27 | 35 | 38 | ||
3 | M | 55 | No | 0 | 140 | 160 | 173 | 79 | 96 | |
4 | F | 56 | No | 0 | 37 | 40 | 45 | 46 | 36 | 28 |
The 8th to 14th monitoring | 40 | 35 | 35 | 99 | 36 | 43 | 46 | |||
5 | F | 55 | Yes | 0 | 42 | 229 | 107 | 152 | ||
6 | M | 79 | No | 0 | 32 | 65 | 29 | 33 | ||
7 | M | 63 | Yes | 0 | 28 | 31 | 154 | 88 | 98 | 55 |
8 | M | 55 | No | 0 | 52 | 35 | ||||
9 | M | 77 | No | 0 | 41 | 84 | 21 | 122 | ||
10 | M | 74 | No | 0 | 28 | 38 | 76 | 53 | 71 | 104 |
11 | M | 68 | Yes | 0 | 301 | |||||
12 | M | 72 | Yes | 0 | 61 | 30 | ||||
13 | M | 79 | Yes | 0 | 70 | |||||
14 | F | 72 | Yes | 0 | 58 | 31 | 29 | |||
15 | M | 60 | Yes | 0 | 101 | 140 | ||||
16 | M | 53 | Yes | 0 | 367 | 116 | ||||
17 | F | 67 | No | 0 | 407 | 343 | 176 | 43 | ||
18 | M | 70 | No | 0 | 169 | 221 | ||||
19 | F | 66 | Yes | 0 | 47 | 31 | 35 | |||
20 | M | 53 | Yes | 0 | 32 | 17 | 105 | 510 | 43 | |
21 | F | 56 | Yes | 0 | 100 | 106 | ||||